Details of the Drug Combinations

General Information of This Drug (ID: DM7RJXL)

Drug Name
Imatinib   DM7RJXL
Synonyms
Cgp 57148; Glamox; Glamox (TN); Gleevec (TN); Glivec (TN); Imatinib (INN); Imatinib (STI571); Imatinib Methansulfonate; Imatinib [INN:BAN]; 112GI019; 152459-95-5; BKJ8M8G5HI; CCRIS 9076; CGP-57148; CHEMBL941; Imatinib free base; STI; UNII-BKJ8M8G5HI
Indication
Disease Entry ICD 11 Status REF
Acute lymphoblastic leukaemia 2A85 Approved [1]
Blast phase chronic myelogenous leukemia, BCR-ABL1 positive N.A. Approved [2]
Choroidal neovascularization 9B76 Approved [2]
Chronic eosinophilic leukemia N.A. Approved [2]
Chronic myelogenous leukaemia 2A20.0 Approved [3]
Chronic myeloid leukaemia 2A20 Approved [4]
Dermatofibrosarcoma protuberans N.A. Approved [2]
Gastrointestinal stromal tumour 2B5B Approved [2]
Leukemia N.A. Approved [2]
Malignant peripheral nerve sheath tumor N.A. Approved [2]
Myeloproliferative neoplasm 2A20 Approved [2]
Pulmonary hypertension BB01 Approved [2]
Coronavirus Disease 2019 (COVID-19) 1D6Y Phase 3 [5]
Intestinal cancer 2C0Z Phase 3 [3]
Lung cancer 2C25.0 Phase 2 [3]
Idiopathic hypereosinophilic syndrome N.A. Investigative [2]
Middle East Respiratory Syndrome (MERS) 1D64 Investigative [6]
Scleroderma 4A42 Investigative [2]
Severe acute respiratory syndrome (SARS) 1D65 Investigative [6]
Systemic mastocytosis 2A21.0 Investigative [7]
⏷ Show the Full List of Indication(s)
Therapeutic Class
Anticancer Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

616 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
1-((2-chlorophenyl)diphenylmethyl)-1H-pyrazole + Imatinib DCTQ2Y7 1-((2-chlorophenyl)diphenylmethyl)-1H-pyrazole Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
ABIRATERONE + Imatinib DCCC1YP ABIRATERONE Chronic myelogenous leukemia (Cell Line: K-562) [8]
ABIRATERONE + Imatinib DCV4TFS ABIRATERONE Clear cell renal cell carcinoma (Cell Line: CAKI-1) [8]
ABIRATERONE + Imatinib DC6O0ZI ABIRATERONE Renal cell carcinoma (Cell Line: SN12C) [8]
ABIRATERONE + Imatinib DC0UBUH ABIRATERONE Breast adenocarcinoma (Cell Line: MDA-MB-468) [9]
ABIRATERONE + Imatinib DCXHJKD ABIRATERONE High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [10]
ABIRATERONE + Imatinib DCYFODK ABIRATERONE Large cell lung carcinoma (Cell Line: NCI-H460) [10]
ABIRATERONE + Imatinib DC99V1S ABIRATERONE Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [10]
ABIRATERONE + Imatinib DCRZQ3K ABIRATERONE Prostate carcinoma (Cell Line: PC-3) [10]
Acamprosate + Imatinib DCNVSCP Acamprosate Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Acarbose + Imatinib DCK2QKY Acarbose Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Acetazolamide + Imatinib DCI5QJP Acetazolamide Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Acetohexamide + Imatinib DCVS1FH Acetohexamide Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Aliskiren + Imatinib DC8N9TO Aliskiren Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Allopurinol + Imatinib DC3PI46 Allopurinol Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Aminosalicylic acid + Imatinib DC9Q3EC Aminosalicylic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Amodiaquine + Imatinib DCQOEZ7 Amodiaquine Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Amonafide + Imatinib DCXL79S Amonafide Adenocarcinoma (Cell Line: HCT-15) [8]
Amonafide + Imatinib DCXDOOR Amonafide Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [8]
Amonafide + Imatinib DCBWD1I Amonafide Chronic myelogenous leukemia (Cell Line: K-562) [8]
Amonafide + Imatinib DCTG33Q Amonafide Clear cell renal cell carcinoma (Cell Line: 786-0) [8]
Amonafide + Imatinib DCT95YY Amonafide High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [8]
Anastrozole + Imatinib DCSXXU6 Anastrozole Adenocarcinoma (Cell Line: A549) [8]
Anastrozole + Imatinib DCVNGDA Anastrozole Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [8]
Anastrozole + Imatinib DCSN8I0 Anastrozole Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [8]
Anastrozole + Imatinib DC3ATZK Anastrozole Amelanotic melanoma (Cell Line: M14) [8]
Anastrozole + Imatinib DCSVNE4 Anastrozole Anaplastic large cell lymphoma (Cell Line: SR) [8]
Anastrozole + Imatinib DCNLN84 Anastrozole Chronic myelogenous leukemia (Cell Line: K-562) [8]
Anastrozole + Imatinib DCLY4CC Anastrozole Clear cell renal cell carcinoma (Cell Line: 786-0) [8]
Anastrozole + Imatinib DCLU836 Anastrozole Cutaneous melanoma (Cell Line: SK-MEL-28) [8]
Anastrozole + Imatinib DCB2979 Anastrozole Glioma (Cell Line: SF-295) [8]
Anastrozole + Imatinib DC2Z2Y7 Anastrozole Glioma (Cell Line: SF-268) [8]
Anastrozole + Imatinib DCG1TUA Anastrozole High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [8]
Anastrozole + Imatinib DCLKH34 Anastrozole High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [8]
Anastrozole + Imatinib DCBM9NN Anastrozole Malignant melanoma (Cell Line: LOX IMVI) [8]
Anastrozole + Imatinib DC598OR Anastrozole Melanoma (Cell Line: UACC-257) [8]
Anastrozole + Imatinib DCHK93B Anastrozole Melanoma (Cell Line: MALME-3M) [8]
Anastrozole + Imatinib DC5VZYY Anastrozole Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [8]
Anastrozole + Imatinib DC36EZF Anastrozole Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [8]
Anastrozole + Imatinib DCOC6TY Anastrozole Invasive ductal carcinoma (Cell Line: BT-549) [9]
Arfolitixorin + Imatinib DCWVIVX Arfolitixorin Astrocytoma (Cell Line: SNB-19) [8]
Arfolitixorin + Imatinib DCS9PQU Arfolitixorin Glioma (Cell Line: SF-295) [8]
Arfolitixorin + Imatinib DCIQDHL Arfolitixorin Carcinoma (Cell Line: MCF7) [9]
Arfolitixorin + Imatinib DC6CIXM Arfolitixorin Adenocarcinoma (Cell Line: HCT116) [10]
Armodafinil + Imatinib DCKKGBE Armodafinil Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
AS-1949490 + Imatinib DC6ZR26 AS-1949490 Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Atenolol + Imatinib DC5CT5E Atenolol Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
BIO-300 + Imatinib DCJXURL BIO-300 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [8]
BIO-300 + Imatinib DCRJYA2 BIO-300 Chronic myelogenous leukemia (Cell Line: K-562) [8]
BIO-300 + Imatinib DC61UM6 BIO-300 Plasma cell myeloma (Cell Line: RPMI-8226) [8]
BIO-300 + Imatinib DCXBE5R BIO-300 Breast adenocarcinoma (Cell Line: MDA-MB-468) [9]
BIO-300 + Imatinib DCHB5ZM BIO-300 Carcinoma (Cell Line: RXF 393) [9]
BIO-300 + Imatinib DCL4XN1 BIO-300 Invasive ductal carcinoma (Cell Line: T-47D) [9]
BIO-300 + Imatinib DC1XWMT BIO-300 Adenocarcinoma (Cell Line: HCT-15) [10]
BIO-300 + Imatinib DCCNCMD BIO-300 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [10]
Bleomycin + Imatinib DC9KP47 Bleomycin Adenocarcinoma (Cell Line: HCT-15) [10]
Brincidofovir + Imatinib DCBWJKH Brincidofovir Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Bumetanide + Imatinib DC40RTQ Bumetanide Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Cabazitaxel + Imatinib DC19EMB Cabazitaxel Adenocarcinoma (Cell Line: HCT-15) [8]
Cabazitaxel + Imatinib DCI21S6 Cabazitaxel Chronic myelogenous leukemia (Cell Line: K-562) [8]
Cabazitaxel + Imatinib DC65D0X Cabazitaxel Lung adenocarcinoma (Cell Line: NCI-H522) [8]
Cabazitaxel + Imatinib DCMS93T Cabazitaxel Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [8]
Carglumic acid + Imatinib DC9SNVG Carglumic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Cefmenoxime + Imatinib DCGBVZV Cefmenoxime Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Chlormezanone + Imatinib DCNNDX2 Chlormezanone Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Chloroquine + Imatinib DCIW0MI Chloroquine Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Cilostazol + Imatinib DC14EQI Cilostazol Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Cinacalcet + Imatinib DCUD3VK Cinacalcet Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Ciprofibrate + Imatinib DCL3AQM Ciprofibrate Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Clopidogrel + Imatinib DC1EVEN Clopidogrel Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Crizotinib + Imatinib DCOSU67 Crizotinib Adenocarcinoma (Cell Line: OVCAR3) [8]
Crizotinib + Imatinib DC2M3GQ Crizotinib Astrocytoma (Cell Line: U251) [8]
Crizotinib + Imatinib DCYLG08 Crizotinib Chronic myelogenous leukemia (Cell Line: K-562) [8]
Crizotinib + Imatinib DCCA60I Crizotinib Large cell lung carcinoma (Cell Line: NCI-H460) [8]
Crizotinib + Imatinib DCMAGFQ Crizotinib Melanoma (Cell Line: UACC-257) [8]
Crizotinib + Imatinib DCK6T8D Crizotinib Invasive ductal carcinoma (Cell Line: T-47D) [9]
Cycloguanil + Imatinib DC1RPO1 Cycloguanil Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Dacarbazine + Imatinib DCOZP5K Dacarbazine Adenocarcinoma (Cell Line: HCC-2998) [8]
Dacarbazine + Imatinib DCACFOU Dacarbazine Adenocarcinoma (Cell Line: HCT116) [8]
Dacarbazine + Imatinib DCAJ562 Dacarbazine Adenocarcinoma (Cell Line: SW-620) [8]
Dacarbazine + Imatinib DCZ09SE Dacarbazine Amelanotic melanoma (Cell Line: MDA-MB-435) [8]
Dacarbazine + Imatinib DCJ5KRD Dacarbazine Amelanotic melanoma (Cell Line: M14) [8]
Dacarbazine + Imatinib DC0XOD5 Dacarbazine Anaplastic large cell lymphoma (Cell Line: SR) [8]
Dacarbazine + Imatinib DC9OEFF Dacarbazine Astrocytoma (Cell Line: SNB-19) [8]
Dacarbazine + Imatinib DCBLRNM Dacarbazine Glioma (Cell Line: SF-295) [8]
Dacarbazine + Imatinib DC9YKWC Dacarbazine Glioma (Cell Line: SF-268) [8]
Dacarbazine + Imatinib DCHQAZR Dacarbazine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [8]
Dacarbazine + Imatinib DCJB1QL Dacarbazine Lung adenocarcinoma (Cell Line: HOP-62) [8]
Dacarbazine + Imatinib DCXZ207 Dacarbazine Malignant melanoma (Cell Line: LOX IMVI) [8]
Dacarbazine + Imatinib DCZS4R8 Dacarbazine Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [8]
Dacarbazine + Imatinib DC8DN8V Dacarbazine Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [8]
Dacarbazine + Imatinib DC8NZZY Dacarbazine Carcinoma (Cell Line: MCF7) [9]
Dactinomycin + Imatinib DCWIKOG Dactinomycin Colon carcinoma (Cell Line: KM12) [9]
Dactinomycin + Imatinib DCWVWLC Dactinomycin Adenocarcinoma (Cell Line: NCIH23) [10]
Dactinomycin + Imatinib DC4GWDK Dactinomycin Adenocarcinoma (Cell Line: A549) [10]
Dactinomycin + Imatinib DCW9TUY Dactinomycin Adenocarcinoma (Cell Line: HCT116) [10]
Dactinomycin + Imatinib DC69WGR Dactinomycin Adenocarcinoma (Cell Line: HT29) [10]
Dactinomycin + Imatinib DCQGJKJ Dactinomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [10]
Dactinomycin + Imatinib DCJQIPX Dactinomycin Amelanotic melanoma (Cell Line: M14) [10]
Dactinomycin + Imatinib DCKEV7X Dactinomycin Astrocytoma (Cell Line: U251) [10]
Dactinomycin + Imatinib DC8767S Dactinomycin Chronic myelogenous leukemia (Cell Line: K-562) [10]
Dactinomycin + Imatinib DCQL3XU Dactinomycin Clear cell renal cell carcinoma (Cell Line: A498) [10]
Dactinomycin + Imatinib DCSI9D3 Dactinomycin Clear cell renal cell carcinoma (Cell Line: TK-10) [10]
Dactinomycin + Imatinib DCNDJBX Dactinomycin Clear cell renal cell carcinoma (Cell Line: 786-0) [10]
Dactinomycin + Imatinib DC7N931 Dactinomycin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [10]
Dactinomycin + Imatinib DCAPP5B Dactinomycin Glioma (Cell Line: SF-539) [10]
Dactinomycin + Imatinib DCEUHMM Dactinomycin Glioma (Cell Line: SF-268) [10]
Dactinomycin + Imatinib DCQALY9 Dactinomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [10]
Dactinomycin + Imatinib DC89D8U Dactinomycin Large cell lung carcinoma (Cell Line: NCI-H460) [10]
Dactinomycin + Imatinib DC700AJ Dactinomycin Lung adenocarcinoma (Cell Line: MDA-MB-231) [10]
Dactinomycin + Imatinib DC4P236 Dactinomycin Lung adenocarcinoma (Cell Line: NCI-H522) [10]
Dactinomycin + Imatinib DCMX5PS Dactinomycin Malignant melanoma (Cell Line: LOX IMVI) [10]
Dactinomycin + Imatinib DC28TD9 Dactinomycin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [10]
Dactinomycin + Imatinib DCYYWW7 Dactinomycin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [10]
Dactinomycin + Imatinib DCXFBXJ Dactinomycin Papillary renal cell carcinoma (Cell Line: ACHN) [10]
Dactinomycin + Imatinib DCIWOZM Dactinomycin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [10]
Dactinomycin + Imatinib DCIYZF2 Dactinomycin Prostate carcinoma (Cell Line: PC-3) [10]
Dexrazoxane + Imatinib DCUB7X7 Dexrazoxane Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [8]
Dexrazoxane + Imatinib DC6HFRD Dexrazoxane Adenocarcinoma (Cell Line: HCT116) [10]
Dexrazoxane + Imatinib DC7H860 Dexrazoxane High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [10]
Dextromethorphan + Imatinib DCQVXNT Dextromethorphan Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
DFN-15 + Imatinib DC6S52T DFN-15 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [10]
DFN-15 + Imatinib DCASB7B DFN-15 Non-small cell lung carcinoma (Cell Line: HOP-92) [10]
Diethylcarbamazine + Imatinib DC87BB2 Diethylcarbamazine Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Digitoxin + Imatinib DCLZ4B7 Digitoxin Large cell lung carcinoma (Cell Line: NCI-H460) [8]
Digitoxin + Imatinib DC9FNOX Digitoxin Invasive ductal carcinoma (Cell Line: T-47D) [9]
Diphenidol + Imatinib DCWBY8B Diphenidol Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Doxorubicin + Imatinib DCKEUS7 Doxorubicin Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Epirubicin + Imatinib DCCUUCL Epirubicin Clear cell renal cell carcinoma (Cell Line: TK-10) [8]
Epirubicin + Imatinib DCBAXMD Epirubicin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [8]
Epirubicin + Imatinib DCLXZCK Epirubicin Papillary renal cell carcinoma (Cell Line: ACHN) [8]
Epirubicin + Imatinib DC4PGXS Epirubicin Renal cell carcinoma (Cell Line: SN12C) [8]
Epirubicin + Imatinib DCOYKJ6 Epirubicin Invasive ductal carcinoma (Cell Line: HS 578T) [9]
Epirubicin + Imatinib DC64ZEF Epirubicin Invasive ductal carcinoma (Cell Line: BT-549) [9]
Epirubicin + Imatinib DCEDXWV Epirubicin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [10]
Epirubicin + Imatinib DCFQQFU Epirubicin Large cell lung carcinoma (Cell Line: NCI-H460) [10]
Epirubicin + Imatinib DC0HR48 Epirubicin Malignant melanoma (Cell Line: UACC62) [10]
Epirubicin + Imatinib DCM2QUW Epirubicin Melanoma (Cell Line: UACC-257) [10]
Epirubicin + Imatinib DCUK4GM Epirubicin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [10]
Epirubicin + Imatinib DCR1EHD Epirubicin Prostate carcinoma (Cell Line: PC-3) [10]
Eptifibatide + Imatinib DCPKSOL Eptifibatide Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Estramustine + Imatinib DCTUEGY Estramustine Carcinoma (Cell Line: MCF7) [9]
Ethinyl estradiol + Imatinib DC1EEK3 Ethinyl estradiol Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
ETHISTERONE + Imatinib DCGLF4J ETHISTERONE Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Etomidate + Imatinib DCI0PSO Etomidate Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Fomepizole + Imatinib DCNVJC8 Fomepizole Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Gefitinib + Imatinib DCM1VGD Gefitinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [8]
Gefitinib + Imatinib DC0I4BT Gefitinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [8]
Gefitinib + Imatinib DCDB6PV Gefitinib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [8]
Gefitinib + Imatinib DC77KMM Gefitinib Chronic myelogenous leukemia (Cell Line: K-562) [8]
Gefitinib + Imatinib DC9K7IM Gefitinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [8]
Gefitinib + Imatinib DC3RA6K Gefitinib Lung adenocarcinoma (Cell Line: MDA-MB-231) [8]
Gefitinib + Imatinib DC66PA5 Gefitinib Melanoma (Cell Line: UACC-257) [8]
GS4071 + Imatinib DCOZVGV GS4071 Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Hydralazine + Imatinib DCT34XI Hydralazine Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Hydroxychloroquine + Imatinib DCCTFOL Hydroxychloroquine Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Idarubicin + Imatinib DCWJW9P Idarubicin Astrocytoma (Cell Line: SNB-19) [8]
Idarubicin + Imatinib DCZFDFX Idarubicin Invasive ductal carcinoma (Cell Line: HS 578T) [9]
Idarubicin + Imatinib DCN7TMH Idarubicin Melanoma (Cell Line: UACC-257) [10]
Idarubicin + Imatinib DCP0317 Idarubicin Melanoma (Cell Line: MALME-3M) [10]
Imatinib + Aprepitant DCBVQP7 Aprepitant Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Ribavirin-TP DCAB5G1 Ribavirin-TP Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Lefaxin DCTIW5C Lefaxin Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Pentostatin DCXS0JO Pentostatin Adenocarcinoma (Cell Line: NCIH23) [8]
Imatinib + Pentostatin DCI3SMD Pentostatin Adenocarcinoma (Cell Line: HCT-15) [8]
Imatinib + Pentostatin DCWYYA1 Pentostatin Adenocarcinoma (Cell Line: HT29) [8]
Imatinib + Pentostatin DC16VE6 Pentostatin Amelanotic melanoma (Cell Line: MDA-MB-435) [8]
Imatinib + Pentostatin DC14D51 Pentostatin Anaplastic large cell lymphoma (Cell Line: SR) [8]
Imatinib + Pentostatin DCY39V2 Pentostatin Clear cell renal cell carcinoma (Cell Line: TK-10) [8]
Imatinib + Pentostatin DCIK2TG Pentostatin Lung adenocarcinoma (Cell Line: HOP-62) [8]
Imatinib + Baclofen DC9F7EV Baclofen Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Bepridil DCQIBBF Bepridil Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Fulvestrant DC51RE0 Fulvestrant Clear cell renal cell carcinoma (Cell Line: TK-10) [8]
Imatinib + Lumefantrine DCLLOA8 Lumefantrine Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Hepzato DCXUSJ2 Hepzato Adenocarcinoma (Cell Line: HT29) [8]
Imatinib + Citalopram DCX74MH Citalopram Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Imipramine DCHPALV Imipramine Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Ixabepilone DCW8SFD Ixabepilone Chronic myelogenous leukemia (Cell Line: K-562) [8]
Imatinib + Ixabepilone DCYUYEK Ixabepilone Clear cell renal cell carcinoma (Cell Line: 786-0) [8]
Imatinib + Ixabepilone DC2HUE5 Ixabepilone Cutaneous melanoma (Cell Line: SK-MEL-5) [8]
Imatinib + Ixabepilone DC9SLFG Ixabepilone Lung adenocarcinoma (Cell Line: EKVX) [8]
Imatinib + Dactinomycin DCLE6M3 Dactinomycin Glioblastoma (Cell Line: SNB-75) [8]
Imatinib + Dactinomycin DCEHDKO Dactinomycin Renal cell carcinoma (Cell Line: UO-31) [8]
Imatinib + Lapatinib DC5WBUY Lapatinib Anaplastic large cell lymphoma (Cell Line: SR) [8]
Imatinib + Epinephrine DCXU1D4 Epinephrine Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Tindamax DCTJ1R2 Tindamax Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Furazolidone DCO1RV9 Furazolidone Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Chlorphenesin DC006PC Chlorphenesin Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + GYKI-52466 DCUM7JJ GYKI-52466 Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + PMID28460551-Compound-2 DCPV0ZY PMID28460551-Compound-2 Chronic myelogenous leukemia (Cell Line: K-562) [8]
Imatinib + Cyclophosphamide DCX0419 Cyclophosphamide Adenocarcinoma (Cell Line: OVCAR3) [8]
Imatinib + Cyclophosphamide DCT4V4E Cyclophosphamide Adenocarcinoma (Cell Line: HCT116) [8]
Imatinib + Cyclophosphamide DC4H7IS Cyclophosphamide Adenocarcinoma (Cell Line: HCT-15) [8]
Imatinib + Cyclophosphamide DCOKVMI Cyclophosphamide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [8]
Imatinib + Cyclophosphamide DCWTDXQ Cyclophosphamide Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [8]
Imatinib + Cyclophosphamide DC6P32I Cyclophosphamide Cutaneous melanoma (Cell Line: SK-MEL-28) [8]
Imatinib + Cyclophosphamide DCRQQ91 Cyclophosphamide Malignant melanoma (Cell Line: LOX IMVI) [8]
Imatinib + Cyclophosphamide DCVEFNH Cyclophosphamide Melanoma (Cell Line: UACC-257) [8]
Imatinib + Cyclophosphamide DCHENJJ Cyclophosphamide Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [8]
Imatinib + Tacrine DC0B1RF Tacrine Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Trioxsalen DCCKTMP Trioxsalen Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Isoniazid DCGIUQ3 Isoniazid Adenocarcinoma (Cell Line: HCT-15) [8]
Imatinib + Isoniazid DCRCBSS Isoniazid Astrocytoma (Cell Line: U251) [8]
Imatinib + Isoniazid DCN1IEK Isoniazid Chronic myelogenous leukemia (Cell Line: K-562) [8]
Imatinib + Pazopanib HCl DC4G760 Pazopanib HCl Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Ezetimibe DCIQ66Z Ezetimibe Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Testosterone DC8TOXE Testosterone Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Nilotinib DCW2V47 Nilotinib Adenocarcinoma (Cell Line: HT29) [8]
Imatinib + Nilotinib DCTTI1G Nilotinib Amelanotic melanoma (Cell Line: MDA-MB-435) [8]
Imatinib + Nilotinib DCVCH18 Nilotinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [8]
Imatinib + Nilotinib DCU1J46 Nilotinib Lung adenocarcinoma (Cell Line: HOP-62) [8]
Imatinib + Triapine DC9I9P4 Triapine Adenocarcinoma (Cell Line: HCT116) [8]
Imatinib + Triapine DCU0JBH Triapine Amelanotic melanoma (Cell Line: MDA-MB-435) [8]
Imatinib + Triapine DC7XODB Triapine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [8]
Imatinib + Everolimus DCSZVMJ Everolimus Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Dexmedetomidine DCNQ8ID Dexmedetomidine Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Pepstatin DCNNTKC Pepstatin Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + 10-hydroxycamptothecin DC5ADTT 10-hydroxycamptothecin Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Dronedarone DC4GYC9 Dronedarone Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Topetecan DCMANX9 Topetecan Chronic myelogenous leukemia (Cell Line: K-562) [8]
Imatinib + Pralatrexate DCWGM0O Pralatrexate Prostate carcinoma (Cell Line: PC-3) [8]
Imatinib + Methylergonovine DCC079E Methylergonovine Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Buspirone DCPDEH8 Buspirone Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Terameprocol DCIU24C Terameprocol Adenocarcinoma (Cell Line: NCIH23) [8]
Imatinib + Terameprocol DCM8K3N Terameprocol Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [8]
Imatinib + Terameprocol DCAL5PJ Terameprocol Malignant melanoma (Cell Line: LOX IMVI) [8]
Imatinib + SCH 727965 DCT0BSR SCH 727965 Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Emetine DC9C39J Emetine Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Ifosfamide DC8VT0U Ifosfamide Adenocarcinoma (Cell Line: OVCAR3) [8]
Imatinib + Ifosfamide DC5K5Y7 Ifosfamide Adenocarcinoma (Cell Line: HCT116) [8]
Imatinib + Ifosfamide DC70N9C Ifosfamide High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [8]
Imatinib + Ifosfamide DCCNPLA Ifosfamide Lung adenocarcinoma (Cell Line: HOP-62) [8]
Imatinib + Ifosfamide DCO2LBS Ifosfamide Non-small cell lung carcinoma (Cell Line: HOP-92) [8]
Imatinib + Ursodeoxycholic acid DCRH5IK Ursodeoxycholic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Doxapram DCKVUKN Doxapram Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Chlorzoxazone DCXWHIJ Chlorzoxazone Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Metformin DCJKQKV Metformin Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Docetaxel DCHZEE0 Docetaxel Adenocarcinoma (Cell Line: DU-145) [8]
Imatinib + Docetaxel DCCE2O9 Docetaxel Adenocarcinoma (Cell Line: OVCAR3) [8]
Imatinib + Docetaxel DC4P5OX Docetaxel Adenocarcinoma (Cell Line: NCIH23) [8]
Imatinib + Docetaxel DCAQJG2 Docetaxel Adenocarcinoma (Cell Line: A549) [8]
Imatinib + Docetaxel DC4KV1C Docetaxel Adenocarcinoma (Cell Line: HCT-15) [8]
Imatinib + Docetaxel DCQBI4Q Docetaxel Adenocarcinoma (Cell Line: SW-620) [8]
Imatinib + Docetaxel DCWE1YG Docetaxel Adenocarcinoma (Cell Line: HCT116) [8]
Imatinib + Docetaxel DC9ICQZ Docetaxel Adenocarcinoma (Cell Line: HT29) [8]
Imatinib + Docetaxel DCPVNGG Docetaxel Adenocarcinoma (Cell Line: HCC-2998) [8]
Imatinib + Docetaxel DCR6DKU Docetaxel Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [8]
Imatinib + Docetaxel DC5LVK0 Docetaxel Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [8]
Imatinib + Docetaxel DCX0ONH Docetaxel Amelanotic melanoma (Cell Line: MDA-MB-435) [8]
Imatinib + Docetaxel DCPG3T0 Docetaxel Anaplastic large cell lymphoma (Cell Line: SR) [8]
Imatinib + Docetaxel DCYOOYJ Docetaxel Astrocytoma (Cell Line: U251) [8]
Imatinib + Docetaxel DCZYRT1 Docetaxel Astrocytoma (Cell Line: SNB-19) [8]
Imatinib + Docetaxel DC7RAUQ Docetaxel Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [8]
Imatinib + Docetaxel DC08XQ7 Docetaxel Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Docetaxel DCSVNRK Docetaxel Chronic myelogenous leukemia (Cell Line: K-562) [8]
Imatinib + Docetaxel DCTFEYU Docetaxel Clear cell renal cell carcinoma (Cell Line: 786-0) [8]
Imatinib + Docetaxel DCOZ6KM Docetaxel Clear cell renal cell carcinoma (Cell Line: A498) [8]
Imatinib + Docetaxel DCM446X Docetaxel Clear cell renal cell carcinoma (Cell Line: CAKI-1) [8]
Imatinib + Docetaxel DC6WTW8 Docetaxel Cutaneous melanoma (Cell Line: SK-MEL-28) [8]
Imatinib + Docetaxel DCKNOVI Docetaxel Cutaneous melanoma (Cell Line: SK-MEL-5) [8]
Imatinib + Docetaxel DCAWVQ1 Docetaxel Glioblastoma (Cell Line: SNB-75) [8]
Imatinib + Docetaxel DCG9YJ5 Docetaxel Glioma (Cell Line: SF-539) [8]
Imatinib + Docetaxel DCQCQ04 Docetaxel Glioma (Cell Line: SF-295) [8]
Imatinib + Docetaxel DCCIO5D Docetaxel High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [8]
Imatinib + Docetaxel DCHMED2 Docetaxel High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [8]
Imatinib + Docetaxel DC28NQ7 Docetaxel High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [8]
Imatinib + Docetaxel DC3TX6Q Docetaxel Large cell lung carcinoma (Cell Line: NCI-H460) [8]
Imatinib + Docetaxel DCJPF23 Docetaxel Lung adenocarcinoma (Cell Line: EKVX) [8]
Imatinib + Docetaxel DCJ0M16 Docetaxel Lung adenocarcinoma (Cell Line: MDA-MB-231) [8]
Imatinib + Docetaxel DCM930N Docetaxel Lung adenocarcinoma (Cell Line: NCI-H522) [8]
Imatinib + Docetaxel DC2RFXJ Docetaxel Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [8]
Imatinib + Docetaxel DCZS5WD Docetaxel Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [8]
Imatinib + Docetaxel DCLEPQO Docetaxel Papillary renal cell carcinoma (Cell Line: ACHN) [8]
Imatinib + Docetaxel DC974EG Docetaxel Plasma cell myeloma (Cell Line: RPMI-8226) [8]
Imatinib + Docetaxel DCU59V1 Docetaxel Prostate carcinoma (Cell Line: PC-3) [8]
Imatinib + Docetaxel DCHA01E Docetaxel Renal cell carcinoma (Cell Line: SN12C) [8]
Imatinib + Docetaxel DCVE4C7 Docetaxel Renal cell carcinoma (Cell Line: UO-31) [8]
Imatinib + Raloxifene DCG2X15 Raloxifene Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [8]
Imatinib + Raloxifene DCCTOMT Raloxifene Amelanotic melanoma (Cell Line: M14) [8]
Imatinib + Raloxifene DCPINYN Raloxifene High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [8]
Imatinib + Raloxifene DCL5ORZ Raloxifene Malignant melanoma (Cell Line: UACC62) [8]
Imatinib + Cilastatin DC2QPLY Cilastatin Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Pazopanib DCZSD7R Pazopanib Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Daidzin DCYVC45 Daidzin Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Phensuximide DCHPPU0 Phensuximide Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Bendamustine hydrochloride DCXUJ3Q Bendamustine hydrochloride Adenocarcinoma (Cell Line: HCT116) [8]
Imatinib + Bendamustine hydrochloride DCT11YQ Bendamustine hydrochloride Malignant melanoma (Cell Line: UACC62) [8]
Imatinib + Bendamustine hydrochloride DCWPPOE Bendamustine hydrochloride Melanoma (Cell Line: MALME-3M) [8]
Imatinib + Fibrates DCKW3K5 Fibrates Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Sirolimus DC6STGW Sirolimus Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [8]
Imatinib + Sirolimus DCXDO0X Sirolimus Plasma cell myeloma (Cell Line: RPMI-8226) [8]
Imatinib + PHA-739358 DCHJ6FX PHA-739358 Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Mitomycin DC266VA Mitomycin Large cell lung carcinoma (Cell Line: NCI-H460) [8]
Imatinib + Mitomycin DCF0GDQ Mitomycin Lung adenocarcinoma (Cell Line: EKVX) [8]
Imatinib + Mitomycin DC556D3 Mitomycin Lung adenocarcinoma (Cell Line: NCI-H522) [8]
Imatinib + Naringenin DC9K5Q8 Naringenin Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Diphenidol DCKVL9R Diphenidol Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Tolvaptan DCNMK0N Tolvaptan Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Arfolitixorin DCMGJ0H Arfolitixorin Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Triflupromazine DCFGCIX Triflupromazine Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + BIO-300 DCC85V2 BIO-300 Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Eflornithine DC7YRFB Eflornithine Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Norcisapride DCO9PLT Norcisapride Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Trazodone DC5MP5E Trazodone Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Trifluoperazine DCQRZVJ Trifluoperazine Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Altretamine DC15OEU Altretamine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [8]
Imatinib + Altretamine DC6LIM1 Altretamine Amelanotic melanoma (Cell Line: MDA-MB-435) [8]
Imatinib + Altretamine DC2QQ95 Altretamine Astrocytoma (Cell Line: U251) [8]
Imatinib + Altretamine DCKWT04 Altretamine Chronic myelogenous leukemia (Cell Line: K-562) [8]
Imatinib + Altretamine DCEFQBB Altretamine Glioblastoma (Cell Line: SNB-75) [8]
Imatinib + Altretamine DCGDMO4 Altretamine Malignant melanoma (Cell Line: UACC62) [8]
Imatinib + Altretamine DCJBEL7 Altretamine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [8]
Imatinib + Altretamine DCP7WMI Altretamine Prostate carcinoma (Cell Line: PC-3) [8]
Imatinib + Ibutilide DCQTGF0 Ibutilide Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + GINKGOLIDE A DCOZPH5 GINKGOLIDE A Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Diazoxide DCSZOMQ Diazoxide Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Fenoprofen DCNJ99Z Fenoprofen Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Entacapone DCFY60I Entacapone Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + TEM DCQ5ZKZ TEM Adenocarcinoma (Cell Line: NCIH23) [8]
Imatinib + Benserazide DCN1B66 Benserazide Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Pargyline DCJB979 Pargyline Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Idarubicin DC6CELA Idarubicin Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Idarubicin DC3ASTQ Idarubicin Glioblastoma? (Cell Line: T98G) [8]
Imatinib + BRL-15572 DC1BCWG BRL-15572 Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Probenecid DC7J2KK Probenecid Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Abacavir DC7F50U Abacavir Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Pramipexole DCWX3Y0 Pramipexole Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Bortezomib DCD10L7 Bortezomib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [8]
Imatinib + Bortezomib DCFH5TB Bortezomib Chronic myelogenous leukemia (Cell Line: K-562) [8]
Imatinib + Bortezomib DCKTGXB Bortezomib Lung adenocarcinoma (Cell Line: HOP-62) [8]
Imatinib + Acamprosate DCTT768 Acamprosate Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Mesalazine DCHEGET Mesalazine Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Moricizine DC6WOL7 Moricizine Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Artemisinin DC4I4BW Artemisinin Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Valrubicin DCPWWQS Valrubicin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [8]
Imatinib + Valrubicin DCFWURP Valrubicin Renal cell carcinoma (Cell Line: UO-31) [8]
Imatinib + Clascoterone DC3LGXG Clascoterone Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Dopamine DC1UVE8 Dopamine Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Trimethobenzamide DCR4L39 Trimethobenzamide Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Oxyphenbutazone DC6M9YI Oxyphenbutazone Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Ethambutol DCK4C6E Ethambutol Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Novobiocin DCTF1CZ Novobiocin Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Cisplatin DCVCKAO Cisplatin Glioma (Cell Line: SF-539) [8]
Imatinib + Theophylline DCNU9RF Theophylline Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Chlorambucil DC3HYT7 Chlorambucil Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Chlorambucil DCH41QO Chlorambucil High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [8]
Imatinib + Chlorambucil DC138M0 Chlorambucil Lung adenocarcinoma (Cell Line: NCI-H522) [8]
Imatinib + Chlorambucil DCFXGLG Chlorambucil Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [8]
Imatinib + Amiloride DCO7ML9 Amiloride Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Brincidofovir DCJU5Z0 Brincidofovir Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Amantadine DCILVC4 Amantadine Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Sorafenib DCUX9ZY Sorafenib Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + ER819762 DCL7X3D ER819762 Adenocarcinoma (Cell Line: HCT-15) [8]
Imatinib + ER819762 DCR8IUS ER819762 Chronic myelogenous leukemia (Cell Line: K-562) [8]
Imatinib + ER819762 DC6KZ46 ER819762 Glioma (Cell Line: SF-268) [8]
Imatinib + ER819762 DCJQM66 ER819762 Glioma (Cell Line: SF-295) [8]
Imatinib + ER819762 DCUMA1J ER819762 Lung adenocarcinoma (Cell Line: HOP-62) [8]
Imatinib + ER819762 DCAW4F7 ER819762 Lung adenocarcinoma (Cell Line: NCI-H522) [8]
Imatinib + ER819762 DCQTIM8 ER819762 Melanoma (Cell Line: UACC-257) [8]
Imatinib + Romidepsin DCM2R3D Romidepsin Renal cell carcinoma (Cell Line: UO-31) [8]
Imatinib + Loperamide DCY7Y1B Loperamide Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Pomalidomide DCUE5BD Pomalidomide Malignant melanoma (Cell Line: LOX IMVI) [8]
Imatinib + Vinflunine DC0X5TT Vinflunine Adenocarcinoma (Cell Line: OVCAR3) [8]
Imatinib + Vinflunine DCO0VCA Vinflunine Adenocarcinoma (Cell Line: NCIH23) [8]
Imatinib + Vinflunine DC4ZITY Vinflunine Adenocarcinoma (Cell Line: HT29) [8]
Imatinib + Vinflunine DC4YGAD Vinflunine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [8]
Imatinib + Vinflunine DCJP1DG Vinflunine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [8]
Imatinib + Vinflunine DCK7PAN Vinflunine Astrocytoma (Cell Line: U251) [8]
Imatinib + Vinflunine DCE0TXJ Vinflunine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [8]
Imatinib + Vinflunine DCZETHP Vinflunine Clear cell renal cell carcinoma (Cell Line: A498) [8]
Imatinib + Vinflunine DCP8WFA Vinflunine Cutaneous melanoma (Cell Line: SK-MEL-5) [8]
Imatinib + Vinflunine DC7PBS1 Vinflunine Glioblastoma (Cell Line: SNB-75) [8]
Imatinib + Vinflunine DCSI4ZI Vinflunine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [8]
Imatinib + Vinflunine DCLO24B Vinflunine Malignant melanoma (Cell Line: LOX IMVI) [8]
Imatinib + Vinflunine DCGL4GC Vinflunine Malignant melanoma (Cell Line: UACC62) [8]
Imatinib + Vinflunine DC5XFOC Vinflunine Non-small cell lung carcinoma (Cell Line: HOP-92) [8]
Imatinib + Vinflunine DCXYLU7 Vinflunine Plasma cell myeloma (Cell Line: RPMI-8226) [8]
Imatinib + Mycophenolic acid DCHIRP2 Mycophenolic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Hydralazine DCYXFJT Hydralazine Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Mepacrine DCJC5DA Mepacrine Glioma (Cell Line: SF-295) [8]
Imatinib + Mepacrine DCDBY4F Mepacrine Melanoma (Cell Line: SK-MEL-2) [8]
Imatinib + Oxandrolone DCE619O Oxandrolone Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Taxol DCLF0MP Taxol Adenocarcinoma (Cell Line: HT29) [8]
Imatinib + Taxol DCO5HTD Taxol Adenocarcinoma (Cell Line: HCT-15) [8]
Imatinib + Taxol DCFXXLX Taxol Adenocarcinoma (Cell Line: HCC-2998) [8]
Imatinib + Taxol DCLFN0G Taxol Chronic myelogenous leukemia (Cell Line: K-562) [8]
Imatinib + Taxol DC4CQKF Taxol Clear cell renal cell carcinoma (Cell Line: 786-0) [8]
Imatinib + Taxol DCW3XFA Taxol Glioblastoma (Cell Line: SNB-75) [8]
Imatinib + Taxol DCXYNHW Taxol Glioma (Cell Line: SF-295) [8]
Imatinib + Taxol DC0BH3K Taxol High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [8]
Imatinib + Taxol DC08OS5 Taxol Large cell lung carcinoma (Cell Line: NCI-H460) [8]
Imatinib + Taxol DCMVKBW Taxol Renal cell carcinoma (Cell Line: UO-31) [8]
Imatinib + Pizotyline DCY3ZNI Pizotyline Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Fosfomycin DCHXBH5 Fosfomycin Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Lacosamide DCL90KB Lacosamide Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Silver sulfadiazine DCAYRJW Silver sulfadiazine Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Testolactone DCDD0QH Testolactone Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Olmesartan medoxomil DCVS8HP Olmesartan medoxomil Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Auranofin DCM257B Auranofin Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + PMID28870136-Compound-43 DCE4F45 PMID28870136-Compound-43 Adenocarcinoma (Cell Line: HT29) [8]
Imatinib + PMID28870136-Compound-43 DC5LOFH PMID28870136-Compound-43 Adenocarcinoma (Cell Line: HCT116) [8]
Imatinib + PMID28870136-Compound-43 DC90U5G PMID28870136-Compound-43 Lung adenocarcinoma (Cell Line: MDA-MB-231) [8]
Imatinib + PMID28870136-Compound-43 DCDFGGC PMID28870136-Compound-43 Melanoma (Cell Line: MALME-3M) [8]
Imatinib + PMID28870136-Compound-43 DCTI1B9 PMID28870136-Compound-43 Papillary renal cell carcinoma (Cell Line: ACHN) [8]
Imatinib + FORMESTANE DCVW9TL FORMESTANE Anaplastic large cell lymphoma (Cell Line: SR) [8]
Imatinib + Vorinostat DCS2KSP Vorinostat Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Aminolevulinic Acid Hydrochloride DCKV33H Aminolevulinic Acid Hydrochloride Adenocarcinoma (Cell Line: A549) [8]
Imatinib + Cevimeline DCT3KFD Cevimeline Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Estramustine DCPQG6F Estramustine Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Busulfan DCWHF4O Busulfan Adenocarcinoma (Cell Line: HCT-15) [8]
Imatinib + Busulfan DCJDBPT Busulfan Glioma (Cell Line: SF-268) [8]
Imatinib + Busulfan DCX15FU Busulfan Lung adenocarcinoma (Cell Line: MDA-MB-231) [8]
Imatinib + Atovaquone DCSMTCW Atovaquone Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + ML323 DCPVEX6 ML323 Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Aciclovir DC9BYKU Aciclovir Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Enoxacin DC8RZDU Enoxacin Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Raltegravir DCLKJAH Raltegravir Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Acetohydroxamic Acid DCMDWBF Acetohydroxamic Acid Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Dasatinib DC0LHK2 Dasatinib Adenocarcinoma (Cell Line: NCIH23) [8]
Imatinib + Dasatinib DC2C06F Dasatinib Chronic myelogenous leukemia (Cell Line: K-562) [8]
Imatinib + Dasatinib DC7CO1D Dasatinib Clear cell renal cell carcinoma (Cell Line: 786-0) [8]
Imatinib + Dasatinib DCUYI7M Dasatinib Clear cell renal cell carcinoma (Cell Line: TK-10) [8]
Imatinib + Dasatinib DCMG8HW Dasatinib Glioma (Cell Line: SF-539) [8]
Imatinib + Dasatinib DCF3DYK Dasatinib Glioma (Cell Line: SF-268) [8]
Imatinib + Dasatinib DCCQZ9Z Dasatinib Non-small cell lung carcinoma (Cell Line: HOP-92) [8]
Imatinib + Azatadine DCHN09A Azatadine Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Tetracycline DCH8MID Tetracycline Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Imatinib + Ixabepilone DCBWQ7V Ixabepilone Breast adenocarcinoma (Cell Line: MDA-MB-468) [9]
Imatinib + Cyclophosphamide DCHPNQP Cyclophosphamide Colon carcinoma (Cell Line: KM12) [9]
Imatinib + Triapine DC156UT Triapine Carcinoma (Cell Line: RXF 393) [9]
Imatinib + 10-hydroxycamptothecin DCU1J2Q 10-hydroxycamptothecin Breast adenocarcinoma (Cell Line: MDA-MB-468) [9]
Imatinib + Pralatrexate DCC6UGL Pralatrexate Colon adenocarcinoma (Cell Line: COLO 205) [9]
Imatinib + Pralatrexate DC3ND2K Pralatrexate Invasive ductal carcinoma (Cell Line: HS 578T) [9]
Imatinib + SCH 727965 DCK244C SCH 727965 Colon adenocarcinoma (Cell Line: COLO 205) [9]
Imatinib + Ifosfamide DCZU18J Ifosfamide Invasive ductal carcinoma (Cell Line: HS 578T) [9]
Imatinib + Docetaxel DCUT1KL Docetaxel Breast adenocarcinoma (Cell Line: MDA-MB-468) [9]
Imatinib + Docetaxel DCZKSNZ Docetaxel Carcinoma (Cell Line: RXF 393) [9]
Imatinib + Docetaxel DCODCOM Docetaxel Carcinoma (Cell Line: MCF7) [9]
Imatinib + Docetaxel DCKJ0MM Docetaxel Colon adenocarcinoma (Cell Line: COLO 205) [9]
Imatinib + Docetaxel DC23644 Docetaxel Colon carcinoma (Cell Line: KM12) [9]
Imatinib + Docetaxel DCZJP6T Docetaxel Invasive ductal carcinoma (Cell Line: T-47D) [9]
Imatinib + Docetaxel DC4WO2Q Docetaxel Invasive ductal carcinoma (Cell Line: HS 578T) [9]
Imatinib + Docetaxel DC978KK Docetaxel Invasive ductal carcinoma (Cell Line: BT-549) [9]
Imatinib + Mitomycin DCBJA9T Mitomycin Colon carcinoma (Cell Line: KM12) [9]
Imatinib + Chlorambucil DCLNJXQ Chlorambucil Colon carcinoma (Cell Line: KM12) [9]
Imatinib + Vinflunine DCNRFBN Vinflunine Carcinoma (Cell Line: MCF7) [9]
Imatinib + Vinflunine DCYCXD6 Vinflunine Colon carcinoma (Cell Line: KM12) [9]
Imatinib + Mepacrine DC3C6Y5 Mepacrine Carcinoma (Cell Line: MCF7) [9]
Imatinib + PMID28870136-Compound-43 DCVFY9G PMID28870136-Compound-43 Invasive ductal carcinoma (Cell Line: T-47D) [9]
Imatinib + FORMESTANE DCP5S58 FORMESTANE Breast adenocarcinoma (Cell Line: MDA-MB-468) [9]
Imatinib + FORMESTANE DCN8Y7Y FORMESTANE Invasive ductal carcinoma (Cell Line: T-47D) [9]
Imatinib + Dasatinib DCOYCNT Dasatinib Invasive ductal carcinoma (Cell Line: HS 578T) [9]
Indazole derivative 5 + Imatinib DCQZEO2 Indazole derivative 5 Chronic myelogenous leukemia (Cell Line: K-562) [8]
Indazole derivative 5 + Imatinib DCE8LJI Indazole derivative 5 Invasive ductal carcinoma (Cell Line: T-47D) [9]
Indazole derivative 5 + Imatinib DC85YZE Indazole derivative 5 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [10]
Indazole derivative 5 + Imatinib DC0WTD1 Indazole derivative 5 Prostate carcinoma (Cell Line: PC-3) [10]
Isoproterenol + Imatinib DCKYH61 Isoproterenol Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Isosorbide dinitrate + Imatinib DCWVORD Isosorbide dinitrate Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Itraconazole + Imatinib DCH297L Itraconazole Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
K-134 + Imatinib DCWFYED K-134 Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
L-165041 + Imatinib DC7XL4X L-165041 Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Lenalidomide + Imatinib DCSEEUA Lenalidomide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [8]
Lenalidomide + Imatinib DCQF6V7 Lenalidomide Clear cell renal cell carcinoma (Cell Line: TK-10) [8]
Lenalidomide + Imatinib DCV8IR7 Lenalidomide Renal cell carcinoma (Cell Line: UO-31) [8]
Lenalidomide + Imatinib DCIQUWO Lenalidomide Adenocarcinoma (Cell Line: A549) [10]
Lenalidomide + Imatinib DCTF6D3 Lenalidomide High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [10]
Lenalidomide + Imatinib DCJO2W1 Lenalidomide High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [10]
Lenalidomide + Imatinib DC6CGSV Lenalidomide Malignant melanoma (Cell Line: LOX IMVI) [10]
Lenalidomide + Imatinib DCY93FU Lenalidomide Melanoma (Cell Line: MALME-3M) [10]
Letrozole + Imatinib DCDFO44 Letrozole Amelanotic melanoma (Cell Line: M14) [8]
Letrozole + Imatinib DCNXSOS Letrozole High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [8]
Letrozole + Imatinib DCWMG7I Letrozole High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [8]
Letrozole + Imatinib DCMY3T0 Letrozole Lung adenocarcinoma (Cell Line: HOP-62) [8]
Letrozole + Imatinib DCDI7BT Letrozole Melanoma (Cell Line: UACC-257) [8]
Letrozole + Imatinib DCVMW1A Letrozole Non-small cell lung carcinoma (Cell Line: HOP-92) [8]
Letrozole + Imatinib DCJ01KK Letrozole Invasive ductal carcinoma (Cell Line: T-47D) [9]
Levamisole + Imatinib DCJUZPX Levamisole Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
LIAROZOLE + Imatinib DC04XO2 LIAROZOLE Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Lubiprostone + Imatinib DCTVZTC Lubiprostone Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Maraviroc + Imatinib DCWK65A Maraviroc Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Mebendazole + Imatinib DCYNC0Q Mebendazole Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Mebutamate + Imatinib DC3PL11 Mebutamate Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Mecamylamine + Imatinib DCBSR9C Mecamylamine Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Mechlorethamine + Imatinib DCDGI0O Mechlorethamine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [10]
Mechlorethamine + Imatinib DC0YVIF Mechlorethamine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [10]
Mechlorethamine + Imatinib DC8ILC5 Mechlorethamine Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [10]
Meclofenamic acid + Imatinib DCDB6N4 Meclofenamic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Mefloquine + Imatinib DCU3WD2 Mefloquine Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Mephenytoin + Imatinib DCEAYW1 Mephenytoin Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Metaxalone + Imatinib DCZ5KLT Metaxalone Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Methocarbamol + Imatinib DCW23BA Methocarbamol Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Methotrexate + Imatinib DCCEQWP Methotrexate Adenocarcinoma (Cell Line: OVCAR3) [8]
Methotrexate + Imatinib DCRHP4W Methotrexate Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [8]
Methotrexate + Imatinib DCKH32D Methotrexate Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [8]
Methotrexate + Imatinib DC5KNQD Methotrexate Glioma (Cell Line: SF-539) [8]
Methotrexate + Imatinib DCQ5I5A Methotrexate High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [8]
Methotrexate + Imatinib DC0VZ3S Methotrexate Malignant melanoma (Cell Line: LOX IMVI) [8]
Methotrexate + Imatinib DC6YDJR Methotrexate Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [8]
Methotrexate + Imatinib DCCJSX1 Methotrexate Renal cell carcinoma (Cell Line: SN12C) [8]
Methotrexate + Imatinib DC8EJI1 Methotrexate Carcinoma (Cell Line: MCF7) [9]
Methotrexate + Imatinib DCMZNJ7 Methotrexate Colon carcinoma (Cell Line: KM12) [9]
Nabilone + Imatinib DC33HXO Nabilone Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Naltrexone + Imatinib DCA0C6Y Naltrexone Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Nitisinone + Imatinib DCIH7QP Nitisinone Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Nizatidine + Imatinib DCIXXFJ Nizatidine Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Olanzapine + Imatinib DCVOFGS Olanzapine Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Palonosetron + Imatinib DCT2PGM Palonosetron Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Pamidronate + Imatinib DCXS1N2 Pamidronate Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Paromomycin + Imatinib DCO52QY Paromomycin Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Pentamidine + Imatinib DCMTA4A Pentamidine Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
PF-02545920 + Imatinib DC09MS2 PF-02545920 Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
PFK-158 + Imatinib DCKX2D5 PFK-158 Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Picoplatin + Imatinib DC4IGC9 Picoplatin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [8]
Picoplatin + Imatinib DC6TG2I Picoplatin Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Picoplatin + Imatinib DCTEOHU Picoplatin Glioma (Cell Line: SF-268) [8]
Picoplatin + Imatinib DCMI3GJ Picoplatin Renal cell carcinoma (Cell Line: UO-31) [8]
Picoplatin + Imatinib DCMWDVM Picoplatin Renal cell carcinoma (Cell Line: SN12C) [8]
Picoplatin + Imatinib DCXV09H Picoplatin Adenocarcinoma (Cell Line: HCT116) [10]
Picoplatin + Imatinib DC12QCA Picoplatin Amelanotic melanoma (Cell Line: MDA-MB-435) [10]
Picoplatin + Imatinib DCZQCOY Picoplatin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [10]
Picoplatin + Imatinib DCDPG1W Picoplatin Large cell lung carcinoma (Cell Line: NCI-H460) [10]
Picoplatin + Imatinib DCF48G5 Picoplatin Malignant melanoma (Cell Line: LOX IMVI) [10]
Picoplatin + Imatinib DCVK28V Picoplatin Melanoma (Cell Line: SK-MEL-2) [10]
Picoplatin + Imatinib DCAIS0Y Picoplatin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [10]
Picoplatin + Imatinib DCBIPJN Picoplatin Prostate carcinoma (Cell Line: PC-3) [10]
Pinacidil + Imatinib DCVX1CS Pinacidil Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
PMID28870136-Compound-43 + Imatinib DCJDD8I PMID28870136-Compound-43 Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Pomalidomide + Imatinib DCE93H0 Pomalidomide Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Primidone + Imatinib DC91S2F Primidone Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Pyrazinamide + Imatinib DCAUT2A Pyrazinamide Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Raloxifene + Imatinib DCRU5WM Raloxifene Clear cell renal cell carcinoma (Cell Line: 786-0) [8]
Raloxifene + Imatinib DCWKITW Raloxifene Glioma (Cell Line: SF-539) [8]
Raloxifene + Imatinib DC8KK50 Raloxifene Large cell lung carcinoma (Cell Line: NCI-H460) [10]
Rifampin + Imatinib DCC0QL1 Rifampin Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Ruxolitinib + Imatinib DCI8JQS Ruxolitinib Chronic myelogenous leukemia (Cell Line: K-562) [8]
Ruxolitinib + Imatinib DC5DZ62 Ruxolitinib Carcinoma (Cell Line: MCF7) [9]
Ruxolitinib + Imatinib DCXQL46 Ruxolitinib Large cell lung carcinoma (Cell Line: NCI-H460) [10]
Ruxolitinib + Imatinib DCJNO1V Ruxolitinib Prostate carcinoma (Cell Line: PC-3) [10]
Spironolactone + Imatinib DC40C3U Spironolactone Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Sulfapyridine + Imatinib DCNQOWH Sulfapyridine Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Sulfinpyrazone + Imatinib DCRB2S2 Sulfinpyrazone Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
SY-1425 + Imatinib DC4IB4Y SY-1425 Anaplastic large cell lymphoma (Cell Line: SR) [8]
SY-1425 + Imatinib DCC5LYY SY-1425 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [8]
SY-1425 + Imatinib DC1R6F0 SY-1425 Breast adenocarcinoma (Cell Line: MDA-MB-468) [9]
SY-1425 + Imatinib DC7MNHT SY-1425 Invasive ductal carcinoma (Cell Line: T-47D) [9]
SY-1425 + Imatinib DCZKTVJ SY-1425 Lung adenocarcinoma (Cell Line: HOP-62) [10]
SY-1425 + Imatinib DCZ5SCR SY-1425 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [10]
Tacrolimus + Imatinib DCJG69B Tacrolimus Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Tamoxifen + Imatinib DCE1CM9 Tamoxifen Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Terameprocol + Imatinib DC8MUI5 Terameprocol Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Thioguanine + Imatinib DCF2KQ8 Thioguanine Anaplastic large cell lymphoma (Cell Line: SR) [8]
Thioguanine + Imatinib DC6HRCN Thioguanine Astrocytoma (Cell Line: SNB-19) [8]
Thioguanine + Imatinib DCBVO3J Thioguanine Glioblastoma (Cell Line: SNB-75) [8]
Thioguanine + Imatinib DCS3RLQ Thioguanine Glioma (Cell Line: SF-295) [8]
Thioguanine + Imatinib DC9ZH7X Thioguanine Adenocarcinoma (Cell Line: DU-145) [10]
Thioguanine + Imatinib DCSA1CZ Thioguanine Adenocarcinoma (Cell Line: HCT116) [10]
Thioguanine + Imatinib DC3NEL3 Thioguanine High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [10]
Tolazoline + Imatinib DCCAHPP Tolazoline Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Topotecan + Imatinib DC10XIY Topotecan Carcinoma (Cell Line: MCF7) [9]
Topotecan + Imatinib DCIMDQQ Topotecan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [10]
Topotecan + Imatinib DCMJTKE Topotecan Amelanotic melanoma (Cell Line: MDA-MB-435) [10]
Topotecan + Imatinib DC17H1X Topotecan Chronic myelogenous leukemia (Cell Line: KBM-7) [10]
Topotecan + Imatinib DCWM19T Topotecan Glioma (Cell Line: SF-268) [10]
Topotecan + Imatinib DCQS371 Topotecan High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [10]
Topotecan + Imatinib DC8LHHK Topotecan Melanoma (Cell Line: MALME-3M) [10]
Topotecan + Imatinib DC1XXZT Topotecan Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [10]
Topotecan + Imatinib DCGKHKI Topotecan Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [10]
Topotecan + Imatinib DCNKQ3K Topotecan Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [10]
Topotecan + Imatinib DC44Z5Y Topotecan Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [10]
Topotecan + Imatinib DC0JQZK Topotecan Prostate carcinoma (Cell Line: PC-3) [10]
Triamterene + Imatinib DCB9FKY Triamterene Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Trifluridine + Imatinib DCWI7AF Trifluridine Invasive ductal carcinoma (Cell Line: T-47D) [9]
Trifluridine + Imatinib DC9FKWD Trifluridine Cutaneous melanoma (Cell Line: SK-MEL-28) [10]
Trifluridine + Imatinib DC83XHG Trifluridine Melanoma (Cell Line: MALME-3M) [10]
Trifluridine + Imatinib DC4O7TX Trifluridine Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [10]
Trifluridine + Imatinib DCQTG1I Trifluridine Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [10]
Trihexyphenidyl + Imatinib DCUTLVN Trihexyphenidyl Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Trimethobenzamide + Imatinib DCK2CD1 Trimethobenzamide Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Tropisetron + Imatinib DCCLYJ7 Tropisetron Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Uracil mustard + Imatinib DCZML17 Uracil mustard Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [8]
Uracil mustard + Imatinib DCESBZG Uracil mustard Chronic myelogenous leukemia (Cell Line: K-562) [8]
Uracil mustard + Imatinib DCRS2CH Uracil mustard Adenocarcinoma (Cell Line: NCIH23) [10]
Uracil mustard + Imatinib DC4DIOX Uracil mustard Adenocarcinoma (Cell Line: HCT-15) [10]
Uracil mustard + Imatinib DCKIPAO Uracil mustard High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [10]
Valproic Acid + Imatinib DCYL1IK Valproic Acid Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Vandetanib + Imatinib DCV78DD Vandetanib Invasive ductal carcinoma (Cell Line: BT-549) [9]
Vandetanib + Imatinib DCTWD4W Vandetanib Chronic myelogenous leukemia (Cell Line: K-562) [10]
Vandetanib + Imatinib DCFVN2Y Vandetanib Glioma (Cell Line: SF-268) [10]
Vandetanib + Imatinib DCXC1NC Vandetanib Large cell lung carcinoma (Cell Line: NCI-H460) [10]
Vandetanib + Imatinib DCZ6V83 Vandetanib Melanoma (Cell Line: UACC-257) [10]
Vandetanib + Imatinib DC8TVFR Vandetanib Prostate carcinoma (Cell Line: PC-3) [10]
Vemurafenib + Imatinib DCYGAS3 Vemurafenib Carcinoma (Cell Line: MCF7) [9]
Vemurafenib + Imatinib DC29RC5 Vemurafenib Invasive ductal carcinoma (Cell Line: T-47D) [9]
Vemurafenib + Imatinib DCG9OM7 Vemurafenib Astrocytoma (Cell Line: U251) [10]
Vemurafenib + Imatinib DCUHGY8 Vemurafenib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [10]
Vemurafenib + Imatinib DC33FIN Vemurafenib Glioma (Cell Line: SF-295) [10]
Vemurafenib + Imatinib DCULXHR Vemurafenib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [10]
Vemurafenib + Imatinib DCV2M2A Vemurafenib Large cell lung carcinoma (Cell Line: NCI-H460) [10]
Vemurafenib + Imatinib DCZS8YW Vemurafenib Prostate carcinoma (Cell Line: PC-3) [10]
Vincristine + Imatinib DCNR7FT Vincristine Adenocarcinoma (Cell Line: HT29) [8]
Vincristine + Imatinib DCR1N8B Vincristine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [8]
Vincristine + Imatinib DCSCR2C Vincristine Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [8]
Vincristine + Imatinib DC1KNM0 Vincristine Papillary renal cell carcinoma (Cell Line: ACHN) [8]
Vismodegib + Imatinib DC4A3U1 Vismodegib Carcinoma (Cell Line: MCF7) [9]
Vismodegib + Imatinib DC4LEQN Vismodegib Chronic myelogenous leukemia (Cell Line: K-562) [10]
Vismodegib + Imatinib DCOJVF5 Vismodegib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [10]
Vismodegib + Imatinib DCI8VVO Vismodegib Glioma (Cell Line: SF-268) [10]
Vismodegib + Imatinib DCO1G7V Vismodegib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [10]
Vismodegib + Imatinib DC9YZ20 Vismodegib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [10]
Vismodegib + Imatinib DCJ48VI Vismodegib Large cell lung carcinoma (Cell Line: NCI-H460) [10]
Vismodegib + Imatinib DC3KEJX Vismodegib Malignant melanoma (Cell Line: UACC62) [10]
Vismodegib + Imatinib DCOQ025 Vismodegib Prostate carcinoma (Cell Line: PC-3) [10]
Vismodegib + Imatinib DC3J0SJ Vismodegib Renal cell carcinoma (Cell Line: UO-31) [10]
VR-776 + Imatinib DCOMCNM VR-776 Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
WAY-100635 + Imatinib DC54DP6 WAY-100635 Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
Zaleplon + Imatinib DCD8YHY Zaleplon Chronic myelogenous leukemia (Cell Line: KBM-7) [8]
------------------------------------------------------------------------------------
⏷ Show the Full List of 616 DrugCom(s)
23 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
ABL001 + Imatinib DCGV3AT ABL001 Chronic Myelogenous Leukemia [11]
Buparlisib + Imatinib DCXX7IF Buparlisib 3rd Line GIST [12]
Docetaxel + Imatinib DCHH8U7 Docetaxel Breast Cancer [13]
Docetaxel + Imatinib DCKT7LL Docetaxel Metastatic Cancer [14]
Everolimus + Imatinib DCL26ZV Everolimus Gastrointestinal Stromal Tumors [15]
Gemcitabine + Imatinib DC6J2FO Gemcitabine Advanced Pancreatic Cancer [16]
Imatinib + Capecitabine DC6LV9E Capecitabine Breast Cancer [17]
Imatinib + Hydroxyurea DCQYTC7 Hydroxyurea Glioblastoma Multiforme [18]
Methotrexate + Imatinib DCZUUZW Methotrexate Rheumatoid Arthritis [19]
Napabucasin + Imatinib DC6IWKC Napabucasin Hematologic Malignancy [20]
Paclitaxel + Imatinib DCVD20F Paclitaxel Non-small Cell Lung Cancer [21]
Selinexor + Imatinib DCON821 Selinexor Maximum Tolerated Dose [22]
Temozolomide + Imatinib DCPE0D7 Temozolomide Melanoma [23]
Zarnestra + Imatinib DC74S8V Zarnestra Leukemia, Myeloid, Chronic [24]
ABL001 + Imatinib DCRK7IB ABL001 Chronic Phase Chronic Myelogenous Leukemia [25]
Gemcitabine + Imatinib DCV773C Gemcitabine Mesothelioma, Malignant [26]
Imatinib + Dasatinib DCI18X3 Dasatinib Chronic Myeloid Leukemia [27]
Imatinib + Ponatinib DCRZ7C5 Ponatinib Philadelphia Chromosome Positive CML [28]
Nilotinib + Imatinib DCGACF2 Nilotinib Leukemia, Myeloid, Chronic [29]
Nilotinib + Imatinib DCY1DG0 Nilotinib Chronic Myeloid Leukemia [30]
Regorafenib + Imatinib DCQJHXB Regorafenib Gastrointestinal Stromal Tumour [31]
Nilotinib + Imatinib DCCRTDU Nilotinib Leukemia, Chronic Myeloid [32]
Nilotinib + Imatinib DCIMNZR Nilotinib Chronyc Myeloid Leukemia [33]
------------------------------------------------------------------------------------
⏷ Show the Full List of 23 DrugCom(s)

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 Imatinib FDA Label
3 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5687).
4 FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (ANDA) 078340.
5 ClinicalTrials.gov (NCT04356495) Treatments to Decrease the Risk of Hospitalization or Death in Elderly Outpatients With Symptomatic SARS-CoV-2 Infection (COVID-19). U.S. National Institutes of Health.
6 Coronaviruses - drug discovery and therapeutic options. Nat Rev Drug Discov. 2016 May;15(5):327-47.
7 Design and development of antisense drugs. Expert Opin. Drug Discov. 2008 3(10):1189-1207.
8 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
9 Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.
10 Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.
11 ClinicalTrials.gov (NCT02081378) A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALL
12 ClinicalTrials.gov (NCT01468688) A Dose-finding Study of a Combination of Imatinib and BKM120 in the Treatment of 3rd Line GIST Patients
13 ClinicalTrials.gov (NCT00193180) Docetaxel Plus Imatinib Mesylate in Metastatic Breast Cancer
14 ClinicalTrials.gov (NCT00084825) Docetaxel and Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases That Progressed on the Docetaxel and Placebo Group of MDA-ID-030008
15 ClinicalTrials.gov (NCT01275222) Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors
16 ClinicalTrials.gov (NCT01048320) Gemcitabine and Oxaliplatin (Gem-Ox) Plus Glivec in Gemcitabine-refractory Pancreatic Cancer
17 ClinicalTrials.gov (NCT00087152) S0338, Imatinib Mesylate and Capecitabine in Treating Women With Progressive Stage IV Breast Cancer
18 ClinicalTrials.gov (NCT00154375) Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma
19 ClinicalTrials.gov (NCT00154336) A Study of Imatinib 400 mg Once Daily in Combination With Methotrexate in the Treatment of Rheumatoid Arthritis.
20 ClinicalTrials.gov (NCT02352558) A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies
21 ClinicalTrials.gov (NCT01011075) Study of Gleevec and Weekly Paclitaxel in Patients Aged 70 or Older With Advanced Non-small Cell Lung Cancer
22 ClinicalTrials.gov (NCT04138381) Selinexor as Single Agent and With Imatinib in Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (SeliGIST)
23 ClinicalTrials.gov (NCT00667953) Study of Temzolomide and Gleevec in Advanced Melanoma
24 ClinicalTrials.gov (NCT00040105) Zarnestra and Gleevec in Chronic Phase Chronic Myelogenous Leukemia
25 ClinicalTrials.gov (NCT04838041) Protocol Number: HJKC3-0003. Treatment Free Remission After Combination Therapy With Asciminib (ABL001) Plus Tyrosine Kinase Inhibitors (TKI) in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
26 ClinicalTrials.gov (NCT02303899) Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Pleural Mesothelioma
27 ClinicalTrials.gov (NCT03193281) KISS Study: Kinase Inhibition With Sprycel Start up
28 ClinicalTrials.gov (NCT04070443) Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase
29 ClinicalTrials.gov (NCT02269267) The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study)
30 ClinicalTrials.gov (NCT04578847) A Study of REduction And DIscontinuation Treatment of TKI (Imatinib, Nilotinib, Dasatinib and Bosutinib)
31 ClinicalTrials.gov (NCT02365441) A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST)
32 ClinicalTrials.gov (NCT02326311) Optimization of TKIs Treatment and Quality of Life in Ph+ CML Patients ?0 Years in Deep Molecular Response
33 ClinicalTrials.gov (NCT02602314) Sustained Treatment-free Remission in BCR-ABL+ Chronic Myeloid Leukemia